Difference between revisions of "Pharmaceutical committee"
STUART KING (talk | contribs) |
STUART KING (talk | contribs) |
||
| Line 1: | Line 1: | ||
A key activity of the European Commission concerns all those actors involved in the unit or committee meeting up and discussing issues concerning all issues relevant to the other prevailing functions of the unit. | A key activity of the European Commission concerns all those actors involved in the unit or committee meeting up and discussing issues concerning all issues relevant to the other prevailing functions of the unit. | ||
| + | |||
| + | ==Notes== | ||
| + | |||
| + | <references/> | ||
Revision as of 23:20, 3 March 2008
A key activity of the European Commission concerns all those actors involved in the unit or committee meeting up and discussing issues concerning all issues relevant to the other prevailing functions of the unit.
